Proposed change
reason
Reviewed as a class-tension candidate against positive antibody programs.
frontiers / frontier
Reviewable change
back to reviewGantenerumab GRADUATE I and II failed to meet primary clinical endpoints despite amyloid-lowering rationale, reinforcing that target engagement alone does not guarantee clinical translation.
This is a proposal, not yet accepted frontier state. It names what it would change and who proposed it. Only an accepted review event, signed under reviewer authority, writes it into the frontier. Until then it carries no authority over the record.
Proposed change
reason
Reviewed as a class-tension candidate against positive antibody programs.
Provenance
proposed by
reviewer:will-blair-bot
actor type
human
created at
2026-05-06
target type
finding
Affected finding
inspect finding →Gantenerumab GRADUATE I and II failed to meet primary clinical endpoints despite amyloid-lowering rationale, reinforcing that target engagement alone does not guarantee clinical translation.
vf_78e8d7300689c72fThe diff is computed against current frontier state, the same diff a reviewer reads before deciding.
The live diff is computed from a writable workspace. This frontier is read-only here, so the change is shown as recorded without a recomputed before / after.
Canopus treats material changes like reviewable requests: one bounded packet, check output, reviewer decision, and accepted frontier effect.
Anti-amyloid translation in Alzheimer's disease receives a reviewable source, finding, caveat, replication, evaluation, or proof-affecting edit.
The packet names affected record objects, evidence, rationale, reviewer-facing fields, and expected proof impact.
Schema, provenance, benchmark, contradiction, and proof checks decide whether the request is ready to read.
A steward accepts, rejects, caveats, revises, or retracts the request under an inspectable identity.
Only the accepted event mutates frontier state. Atlases, constellations, and search update from that record state.